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ABSTRACT 
Microencapsulation is a promising technique to form microtissues. The existing cell 
microencapsulation technologies that involved extrusion and vibration are designed 
with complex systems and required the use of high energy. A micro-extruder with an 
inclusion of simple vibrator that has the commercial value for creating a 3D cell 
model has been developed in this work. This system encapsulates human 
keratinocytes (HaCaT) in calcium alginate and the size of the microcapsules is 
controllable in the range of 500-800 µm by varying the flow rates of the extruded 
solution and frequency of the vibrator motor (10-63 Hz). At 0.13 ml/min of flow rate 
and vibration rate of 26.4 Hz, approximately 40 ± 10 pieces of the alginate 
microcapsules in a size 632.14 ± 10.35 µm were produced. Approximately 100 µm 
suspension of cells at different cells densities of 1.55 × 10
5 
cells/ml and 1.37 × 10
7 
cells/ml were encapsulated for investigation of microtissues formation. Fourier 
transform infrared spectroscopy (FTIR) analysis showed the different functional 
groups and chemistry contents of the calcium alginate with and without the inclusion 
of HaCaT cells in comparison to the monolayers of HaCaT cells. From Field 
Emission Scanning Electron Microscope (FESEM) imaging, calcium alginate 
microcapsules were characterised by spherical shape and homogenous surface 
morphology. Via the nuclei staining, the distance between cells was found reduced as 
the incubation period increased. This indicated that the cells merged into 
microtissues with good cell-cell adhesions. After 15 days of culture, the cells were 
still viable as indicated by the fluorescence green expression of calcein-
acetoxymethyl. Replating experiment indicated that the cells from the microtissues 
were able to migrate and has the tendency to form monolayer of cells on the culture 
flask. The system was successfully developed and applied to encapsulate cells to 
produce 3D microtissues. 
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ABSTRAK 
 
Pengkapsulanmikro adalah teknik yang menjanjikan pembentukan tisumikro. 
Teknologi sel pemikrokapsulan sedia ada yang melibatkan penyemperitan dan 
getaran telah direka dengan sistem yang kompleks dan memerlukan penggunaan 
tenaga yang tinggi. Pengekstrud mikro dengan penambahan penggetar mudah yang 
mempunyai nilai komersial untuk mewujudkan satu model sel 3D telah telah 
dibangunkan dalam kerja ini. Sistem ini merangkumkan sel kulit manusia (HaCaT) 
dengan kalsium alginat dan saiz kapsulmikro adalah dikawal dalam julat 500-800 
mikron dengan mengubah kadar aliran pengekstrud dan kekerapan motor penggetar 
(10-63 Hz). Pada 0.13 ml/min kadar aliran dan kadar getaran 26.4 Hz, di anggarkan 
40±10 biji kapsulmikro alginat bersaiz 632.14 ± 10.35 µm dapat dihasilkan. Kira-
kira 100 µl kumpulan sel-sel dengan ketumpatan yang berbeza pada 1.55×10
5
 sel/ml 
dan 1.37×10
7
 sel/ml telah di kapsulkan untuk kajian pembentukan tisumikro. 
Analisis FTIR menunjukkan kumpulan berfungsi yang berbeza dan kandungan kimia 
alginat kalsium dengan dan tanpa kemasukan sel HaCaT dan juga monosel HaCaT. 
Dari pengimejan FESEM, kapsulmikro kalsium alginat telah disifatkan  berbentuk 
bulat dan permukaan morfologi homogen. Melalui penandaan nukleus, jarak antara 
sel telah berkurang dengan peningkatan tempoh pengeraman. Ini menunjukkan 
bahawa sel-sel digabungkan menjadi tisumikro yang baik dengan pelekatan sel-sel. 
Selepas 15 hari pengeraman, sel masih hidup seperti yang ditunjukkan oleh 
ungkapan hijau pendarfluor daripada calcein-acetoxymethyl. Pengulangan 
eksperimen menunjukkan bahawa sel-sel dari tisumikro dapat berhijrah dan 
mempunyai kecenderungan untuk membentuk lapisan monosel pada kultur kelalang. 
Sistem ini telah berjaya di bangunkan dan di gunakan untuk merangkumi sel-sel 
untuk menghasilkan tisumikro 3D. 
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 CHAPTER 1  
INTRODUCTION 
1.1 Background of study 
Microencapsulation is the process of coating a biologically active material  to 
form a microcapsule inside a membrane [1–3]. This microencapsulation procedure 
received increasing interest over the last 20 years [4]. This technology shows 
promising potential in agricultural, food industry, cosmetics, and pharmaceutical and 
also biomedicine. Although several microencapsulation methods had been 
developed, but there are some features that can be improved such as 
microencapsulation size to meet the requirements for encapsulating cells.  
Recently, new emerging research has been focusing on creating new 
microencapsulation techniques. Microencapsulation had become more promising 
alternative technique to form the cell spheroids and has the significant potential in 
tissue engineering  [5]. Before moving further towards the microencapsulation 
process itself, there are a few aspects that must be put into consideration. Very basic 
knowledge about the need of microencapsulation is required. The need for 
microencapsulation thrives for improvements of existing microencapsulation 
techniques. 
 The significant interest on microencapsulation using vibration technology 
was gained due to its simplistic approach to produce microcapsules. Based on the 
simpler extrusion and dripping method, the microcapsules formed with a very large 
diameter of 2-5 mm, which is too large for biotechnology or medical application [6]. 
Moreover, some of the technologies used the highly viscous polymers in their system 
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[7]. Previous research had developed the vibrational encapsulation device based on 
vibrating-nozzle to encapsulate the pancreatic islet. However, this technique suffered 
from high complexity and possibly suitable for large number of batches which is not 
suitable for laboratory studies [8].  Therefore, a simple technique based on 
microextrusion with vibration mode is proposed for the microencapsulation of 
human keratinocytes cell lines (HaCaT) in calcium alginate into a size similar to the 
thickness of the epidermis. 
In cell microencapsulation, there are three main components that are being 
focused:  the encapsulated cell lines, type of material or polymer used and the 
microencapsulation technology itself. In typical cell microencapsulation process, 
cells are suspended in a solution, which can become gelled or solidified leading to 
the encapsulation of cells in a matrix. Based on both natural and synthetic polymers, 
hydrogels continued to be a relevant material for encapsulation of cells. Three 
different methods for production of microcapsules include chemical, mechanical and 
physiochemical have been described by previous researchers [8 - 9]. 
 Previously, researcher [11] indicated that microencapsulated particles are 
usually in the size ranging between 1 and 1000 μm depending on the technique used. 
The microencapsulated cells were shown to be able to grow into microtissues or 
encouraged formation of cell aggregates. But, different type of cells reacts with 
bioactive growth factor based on their biocompatibility properties of the 
encapsulation material. The growth factor can provide controlled release into local 
micro-environment to yield desirable concentration periods over a day [12]. 
 Alginate is naturally derived polysaccharides from the brown algae forming 
the linear binary copolymers consisting β-D- mannuronic acid (M) and α-L- 
guluronic acid (G) residues [13]. Sodium alginate has found biomedical and 
biotechnology applications mainly as a material for the encapsulation of a variety of 
cells for immunoisolatory and biochemical processing applications. Although the 
exchange of gases is subjected to diffusion limitations, cells can maintain viability 
within the cross linked gel [14]. It has been employed for encapsulating cells to be 
transplanted, since it is biocompatible both within the host and with enclosed cells 
[15]. 
Creating a three dimensional (3D) cell culture models instead of two 
dimensional (2D) cell model have recently garnered a great attention for 
pharmacological study because of their accuracy of the models in representing the 
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tissue structure in-vivo. Multilayer cell model promotes cell differentiation and tissue 
organisation [1]. For example, organ on chip as regenerative medicine permits the 
study of human physiology in an organ-specific context to create in-vitro organ 
culture microenvironment [2]. Therefore, biomedical engineer are provided with new 
engineering tools to generate the tissue model in multicellular structure and up to the 
extent of creating blood capillary into the tissue model. 
1.2 Problem statement 
The alginate microcapsules can simply be produced by dripping the sodium alginate 
solution into the sodium chloride solution. Simple dripping technique can be used to 
generate microcapsules of alginate but this technique produced microcapsules in the 
range of 1000 to 3000 µm which are too large for the cells to grow. It was reported 
that the optimum size of the microcapsules for the microtissues to grow should be 
less than 1000 µm.  Furthermore, smaller size of capsules can provide better 
transportation of nutrients and oxygen, easier implantation and better mechanical 
strength [11, 16]. Extrusion technology with vibration mode for microencapsulation 
method had been developed. Some of the technologies used the laminar liquid jet 
break up by a superimposed vibration and others used the monocentric or concentric 
nozzle system for cell microencapsulation [7]. However, most of the method comes 
with some disadvantages such as high complexity, difficult to conduct and high 
maintenance [6]. 
 This project is proposed for the development of micro-extruder system that 
could generate controllable size of microcapsule that can form 3D cell. The system is 
straight forward, cost effective and suitable as laboratory scale device. The 
microencapsulation of cells involved calcium alginate that is non-toxic and could be 
removed to extract the microtissues formed. The biophysical structures of the 
microtissues formed is characterised using Fourier Transform Infrared Spectroscopy 
(FTIR), surface morphology using Field Emission Scanning Electron Microscope 
(FESEM), nucleus staining, live and dead assay staining.  
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1.3 Objectives 
The main objectives of the research are: 
a) To design and develop a micro-extruder with vibration mode that generates 
microcapsules for encapsulation of cells. 
b) To encapsulate human keratinocytes in sodium alginate to form 3D cells.  
c) To extract 3D cells from sodium alginate shells using alginate lyase.  
d) To characterise the biophysical properties of the 3D cells.  
1.4  Scope of project 
The design of the micro-extruder system was done using Google Sketch-up. The 
micro-extruder system consists of stepper motor, linear slider, Arduino UNO 
microcontroller, vibrator motor, syringe holder, switches and power supply. The 
stepper motor has different speed which is 5 to 25 rpm referring to the flow rate of 
sodium alginate flow at the range of 0.1 to 0.5 ml/min. The developed micro-
extruder used the stepper motor to control the linear slider that clamp the 0.5 ml 
insulin syringe (BD U-100) to get approximately 500-800μm of microcapsules. 
This study is mainly focus on the extrusion method that can produce 40 ± 10 
numbers of microcapsules for 300 µl of alginate solution at a time. Besides that, 
vibration mode with frequency of 10-63 Hz will be adjusted to get the best size of 
microcapsules. The natural polymer used was calcium alginate which is the 
polymerisation of sodium alginate and calcium chloride solution. Keratinocytes 
(HaCaT) were used in this research because it can keep undergoing division and 
allowed characterisation of several processes. Biophysical characterisation 
characterised the size, shape and morphology of the microcapsules. Analysis such as 
FTIR, FESEM and staining provided information associated with the properties of 
the microcapsules produced. 
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1.5 Organisation of thesis 
Chapter 1 consists of an introduction of thesis covering the problem statement, 
objective and scopes of project. This chapter presented the reader the proper 
understanding about the purpose of this research being carried out. 
 
Chapter 2 covers the microstructure of skin and background of microencapsulation 
including the cell line, technique and material used by previous researcher. Since 
microencapsulation technology had been widely discovered before, so there will be 
many aspects should be taken into consideration to avoid misleading on that fact or 
study. 
 
Chapter 3 basically presents the method used to achieve the objectives of this 
research project. The selection of stepper motor as the main requirement to control 
the extruder is presented. Based on the microcontroller coding, the speed of stepper 
motor can be programmed according to required speed value. The adjustable 
frequency of the vibrator motor also will affect the production of microcapsules. 
Hence, the relationship between speed of motor, frequency of vibrator motor and 
microcapsules size produced can be analysed beside the biophysical analysis of the 
encapsulated cell. 
 
Chapter 4 totally discusses the finding of the work being conducted. Final result on 
experimental study is detailed in this chapter. Figures, graphs and images are 
provided to show the finding and discussions of the finding are also in this chapter. 
 
Chapter 5 finally presented the overall conclusion for this project. The 
recommendation and future work are also discussed in this chapter. 
 
 
 
 
 
CHAPTER 2  
LITERATURE REVIEW 
2.1 Cells and tissue 
The human body composed of trillion numbers of cells. Cells function as basic 
building blocks of all living cells which have the capability to reproduce themselves. 
A cell is the smallest unit of life that has the basic structural, functional and 
biological unit known as living organism with its own function.  It is consist of 
cytoplasm enclosed within a membrane which contains biomolecules include 
proteins and nucleic acid such as nucleus, mitochondria, Golgi apparatus, 
endoplasmic reticulum, lysosome and some other else as shown in Figure 2.1. 
 Tissue is a group or layer of specialised cells that bind together to perform the 
specific functions. In human body, there are four basics types of tissue include 
epithelial, connective, muscular and nervous tissue. Each of the tissues has their 
further classification according to their physiological function. The complex 
combinations and gradients of extracellular matrix (ECM) component with specific 
biological and mechanical influence are having by almost all human tissue. Since the 
interest of reproducing the biomaterial environment for tissue and organ are greatly 
developed, so does the properties of adaptive materials required to recapitulate the 
tissue function [17]. 
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Figure 2.1: A schematic representation of cell 
2.2  Epidermis and human keratinocytes 
Human skin consists of many different types of cells include keratinoctytes, 
melanocytes and fibroblasts [17]. Figure 2.2 illustrates the schematic presentation of 
a skin that depicts the structure of human skin. The outermost tissue and largest 
organ in human body is skin in term of surface area and weight. It has complex 
structure consists of many components such as cells, fibers, and several different 
layers of skin structure. Resulting from chemical and physical reactions inside these 
components, the major function of skin is to act as barrier to the exterior 
environment. Other than that, skin can also prevents water lost from the body and 
regulates body temperature by evaporation of sweat [18].  
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Figure 2.2: A schematic representation of skin 
The term HaCaT (Ha = human adult, Ca = calcium, T= temperature) was 
designed to indicate its origin and the initial culture conditions of normal human 
skin. It was developed through a long term culture of normal human adult skin 
keratinocytes at reduced calcium concentration and elevated temperature [19]. The 
first two lines of skin are NM1 and SIK which are taken from keratinocytes of 
neonatal foreskins. HaCaT is the third lines of keratinocytes isolated from adult 
epidermis (epithelial outer layer of skin) at the periphery of malignant melanoma. 
This cell line is the most extensively characterised of the three spontaneously 
immortalised human keratinocytes cell line [20]. In vitro, HaCaT cell lines exhibit 
the entire of the major surface marker and functional activities characteristic of 
isolated keratinocytes and is able to differentiate, forming stratified epidermal 
structures [21]. The different of HaCaT cell with other human cell include suitable 
for experiment or scientific research. It is also utilised for their high capacity to 
differentiate and proliferate in vitro. Other than that, HaCaT cell allows 
characterisation of several processes and keep undergoing division.  
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2.3 Rational of growing 3D cells 
Conventional two dimensional (2D) cell culture is extensively used in research study 
regenerative medicine and also tissue engineering. This is because of the simplicity 
and reproducibility properties. However, since 1970s, the 2D cell cultures had shown 
their limitation with the increasingly evident and relevance of appropriate for three 
dimensional (3D) cell systems [22].  
 In 2D cell culture, cell-to- plastic interactions occurred rather than cell-to-cell 
and cell-to- extracellular matrix (ECM) interactions that form the normal cell 
function [23]. Since the growth and maintenance of normal tissue is depends on a 
continuous series of cellular interactions in a microenvironment, the various growth 
factors, hormones, adhesion molecules as well as a complex ECM were composed to 
perform their functions [24]. 
 
 
 
 
 
 
 
 
 
 
Figure 2.3: Schematic presentation of cellular distribution in two- and three-
dimensional (2D and 3D) microenvironments 
 
 
 
 
 
 
Cells 
Microfibrillar structure of 
hydrogel 
2D culture 3D culture 
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From the schematic presentation in Figure 2.3, the cellular distribution in 2D and 3D 
microenvironment of cell culture shows the different in term of their structural 
construction. That is the important of the method for producing the 3D microtissues 
because the cell-biomaterial interactions will affect the growth factors of the 
encapsulated cell. Then, the different in cellular characteristics and processes in 2D 
and 3D culture system were summarised in Table 2.1. 
In biological research, cell culture is an important aspect to take as consideration. 
The removal of cells from a tissue before growth on the favorable artificial 
environment is known as culture cell process [25]. The appropriate models system 
can be provided for studying the standard physiology and biochemistry of cells. The 
term ‘3D cell culture’ is referred to a suitable micro-environment for optimal cell 
growth, differentiation and function and the capability to create tissue-like constructs 
in-vitro [26]. 3D cell allowed to increase cell-cell interactions, formation of 
intercellular junctions and intercellular communication, providing a more 
physiologically relevant microsystem [27]. Many attempts had been proposed to 
develop 3D cell culture system mimics the microenvironment to the surrounding cell. 
Table 2.1: Differences in cellular characteristics and processes in two-dimensional 
and three-dimensional culture systems [28] 
Cellular characteristics 2D 3D 
Morphology  Sheet-like flat and stretched in 
monolayer 
Mimic natural shape of cell in 
aggregate structures 
Proliferation  Faster proliferation rate than in vivo Proliferation rate depends on the 
cell types or type of 3D model 
system 
Exposure to 
medium/drugs 
Cells are equally exposed to nutrients 
that are distributed in growth medium 
Some of the nutrients may not fully 
penetrate the spheroid 
Stage of cell cycle Same stage of cell cycle because of 
equally exposed to the medium 
Spheroids contain proliferating, 
quiescent, hypoxic and necrotic 
cells 
Gene/ protein 
expression 
Displays the differential gene and protein 
expression levels 
Exhibit gene/protein expression 
more similar to those in vivo tissue 
origins 
Drug sensitivity Very effective to treatment and drug More resistant to treatment  
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Extracellular matrix (ECM) function as scaffold to maintain tissue and organ 
structure regulates the aspects of cell behavior including cell proliferation and 
growth, survival, change in shape, migration and differentiation. The development of 
all multicellular organisms is influenced by the interaction between cells and the 
ECM. ECM assembly is regulated by the 3 dimensional (3D) environments and the 
cellular tension that is transmitted through integrins [29]. ECM is composed of 
collagen, non-collagenous glycoproteins and proteoglycans.  These components are 
secreted from cells to create an ECM meshwork that surrounds cells and tissues. The 
ECM regulates many aspects of cellular function, including the cells dynamic 
behavior, cytoskeletal organisation and intercellular communication [30].  Today, the 
fabrication of 3D matrices which mimic the better geometry, chemistry and signaling 
environment of natural ECM had been increasing. Hence, the intensive research on 
the interaction between the matrix and cells had been studied. 
Development of material systems in tissue engineering and cell biologists to 
culture mammalian cells within 3D ECM had begun over the past few decades. The 
ability of 3D ECM mimics to circumvent limitation of 2D cell culture traditionally. 
Hence, hydrogel are the most suitable to developing synthetics ECM analogs because 
of the highly attractive material which are able to simulate the nature of most soft 
tissue [31]. As the encapsulated cell with hydrogel can provide the 3D cells with 
tissue-like extracellular environment, they offer several possible applications such as 
in vitro model systems for drug screening, diagnostics tools and toxicological assays 
[32]. In HaCaT cells, integrins appear as the major receptors, by which cells attach to 
the extracellular matrix, and some integrins also mediate important cell-cell adhesion 
events. Moreover, integrins make transmembrane connections to the cytoskeleton 
and activate many intracellular signaling pathways to mediating cell adhesion [33]. 
This cell interaction is as shown in Figure 2.4. 
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Figure 2.4: Cell interactions with polymeric material 
2.4 Methods for growing 3D microtissues 
Productions of microtissues are recently available in many approaches. 3D cell 
cultures give advantages on their technical and functional in many applications. The 
comparison of 3D spheroids or microtissues  formation technique had been discussed 
previously [34]. Basically, the method to produce can be dividing into two categories 
which are scaffold based and scaffold free method. As shown in Table 2.2, each of 
the 3D producing method was discussed briefly. Hydrogels seem to be suitable for 
each of application in tissues engineering. They can exhibit low immunogenicity and 
low cytotoxicity and allows the exchange of gases and nutrients between cells and 
environment [1]. The list of others synthetic and natural polymers for the 3D matrix 
building were listed here [25].  
Scaffolds technique offers the unique clinical opportunities in tissue 
engineering. For scaffolds free method, it consists of microcapsules and spheroid 
formation for producing the 3D microtissues. Each of the method offers different 
output depends on their application. Microencapsulation offer many advantages over 
the conventional method to produce microtissues since it can achieve high densities 
and enhanced product recover [35]. Hanging drop method is not standardised and 
difficult to upscale even though it is cost effective, gentle method and guaranties 
reproducibility [36].  
Integrins 
crosslinked 
alginate network 
ECM 
ECM to cell 
signaling 
Cells 
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Basically, for scaffolds based method there are two types of polymers can be used to 
be the scaffold which are synthetic and natural polymers. To make the biomaterials 
successfully on their application, the biocompatible polymers must be governing 
with suitable morphology and properties to allow the creation of desired molecular 
architectures [37]. Although synthetic biomaterials are good in physical and 
mechanical properties control, but their biocompatibility had an issue during the 
attachment of cell and growth on these materials. 
Table 2.2: Different method of growing 3D microtissues 
 
Categories 
Method for culturing 3D microtissues 
Scaffold free Scaffold based 
Microcapsules Spheroids Synthetic Natural 
Method Electrostatic 
droplet generator 
Hanging drop Freeze drying 3D printing 
Polymers/materials/equipment Calcium alginate 
and gelatin 
Microtiter 
plate 
Polylactic 
acid (PLLA) 
Hyaluronic 
acid (HA) 
Advantages Simple and easier 
to carry out 
Can produce 
spheroids of a 
homogeneous 
size without 
sieving or 
manual 
selection 
Controllable 
degradable 
behaviour 
Cells 
proliferated 
well in the 
designed 
scaffolds 
Application Drug research and 
regenerative 
medicine 
The 
development 
of 
bioartificial 
tissue 
Tissue 
engineering 
Bone tissue 
engineering 
Cell type Feline renal 
fibroblast cell line 
(CRFK) 
Human 
hepatoma cell 
line (HepG2) 
and variety of 
cell line 
Mouse 
fibroblast 
MC3T3-E1 
murine 
fibroblasts 
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2.5 Microencapsulation technology 
Microencapsulation is a promising technique used to encapsulate cells, drugs and 
nanoparticles in polymers. Cell microencapsulation is a technology towards building 
of artificial tissues or organs with the use of bioactive materials or polymeric 
materials [38]. Many techniques [16] had been proposed by previous researcher and 
give a significant advantage to form microcapsules. The idea is to encapsulate the 
cell to form 3D cell that mimic the human environment so that it can be used for 
regenerative medicine, tissue engineering or drug testing. 
In 1999, Stratowa et al. and Taylor et al. in 2001 stated that cell based testing 
method had being progressively employed in the early of discovery drug research 
process. According to Bhadriraju and Chen in 2002, they believed that cell-based 
systems are specifically engineered to mimic in vivo behaviour which can reduce 
costs,  increase efficiencies and predictive accuracy of the drug discovery process 
[39]. 
 Figure 2.5 shows the overall milestone or timeline how the cell 
microencapsulation being started by the previous research. Over the year, more 
invention on the cell microencapsulation had been proposed until now. Over other 
conventional methods for suspension cultures, cell microencapsulation offer many 
advantages such as it can achieve very high cell densities and enhanced product 
recovery [35]. 
In 1931, Bungen burg de Jon et al. were the first people discovered the 
microencapsulation procedure. They prepared gelatin sphere through coacervation 
process. This technique was employed by Bisceglie in 1933 to transplant tumor cells 
in polymeric membrane into a pig’s abdominal cavity. In the 1960’s, Chang  
proposed the first encapsulation for the entrapment of bioactive materials such as 
enzyme, proteins and cells in an immunoprotection semi-permeable membrane. In 
1980s, Lim and Sun had successfully encapsulated implantable islets cells in 
alginate-poly (L-lysine) to form multilayer microcapsules using natural 
polysaccharides based biomaterials which open a new chapter for cell encapsulation. 
 As time progresses, the adherent cells in encapsulation turn into masses of 
microtissues and the value of these microtissues is recognised in pharmacological 
assay, toxicity screening and regenerative medicine. Microencapsulation of drugs is 
aimed to device method for controllable release of drug in the in-vivo system [9]. 
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Figure 2.5: Milestone for cell microencapsulation since its first conception [3, 5, 42] 
A process of enclosing micron-sized particles of solids, droplet of liquids or 
gases in an inert shell is known as microencapsulation. The material inside the 
capsule is referring as core, whereas, the wall is known as shell, coating or 
membrane. Usually, the core material contains an active ingredient whereas the shell 
materials cover or protect the core material [42]. The products with such a structure 
are known as microcapsules, microbeads, microspheres or microparticles. Generally, 
particles having a diameter in the range of 1 to 1000 micrometers are termed as 
microcapsules. On the other hand, spherical encapsulation with size larger than 1000 
micrometers are known as macroparticles (macrospheres) [1, 22].  
The microcapsules or microspheres in different structure of encapsulation are shown 
in Figure 2.6. The differences of these microcapsules are in the stiffness of materials 
and structure of encapsulation. The microcapsules can be fully encapsulated in a 
shell or in a mixture of matrix. Encapsulation efficiency may be reduced due to the 
irregular shape of microcapsules because of the presence of pores [45].  In cell and 
1933 1964 1980 1994 1996 2000 2006 2012 
Chang: concept 
of artificial cells 
First human clinical trial in 
encapsulated islet 
allotrasplantation performed in 
a 38-year-old man with 
diabetes 
Bachoud-levi: first implant into 
ventricles (CNTF for HD) 
Wahlberg: first 
intraparenchymal brain 
implant (NGF and AD) 
Bisceglie: first attempt to 
 encapsulate cells  
Lim: xenograft 
islets 
Intrathecal delivery of CNTF 
using encapsulated 
genetically modified 
xenogeneic cells in patients 
with amyotrophic lateral 
sclerosis 
First intravitreous implantation 
of a cell encapsulation device 
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tissue engineering, microencapsulation is applied in capturing cells microcapsules of 
hydrogels [46]. Microencapsulation can achieve a certain goals set based on their 
application include converting liquids to solids, providing environmental protection, 
altering colloidal, changing surface properties and controlled release characteristic 
[4,23]. The mutli-core structure of microcapsules were applied in this study because 
it mimic the biological cells properties compares to other strucutre. 
 
 
  
 
 
 
 
 
 
 
 
Figure 2.6: Different structures of microcapsules [24–26] 
2.6 Polymeric material for microencapsulation of cells 
Finding the best and suitable materials is challenging in order to get the optimum 
encapsulation result. Many natural and synthetic polymers include hydrogels are 
being tested and reported to be interest for microencapsulation of cells [49]. Table 
2.3 shows the alternative polymers that had been designed and used by previous 
researchers in microencapsulation of cell. Hydrogels are 3D hydrophilic polymer 
networks that absorb water and form swollen material up to thousands times of their 
dry weight in water. Properties include chemically stable or may degrade and 
eventually disintegrate and dissolve allow for efficient transports of nutrients, growth 
factors and drugs to the encapsulated cell [12, 17]. 
Irregular Multi-shell 
Core Shell 
Single core Multi-core Matrix 
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Table 2.3: Alternative microencapsulation material [38] 
Microcapsule design Advantages 
Alg- PLO
 
Increased biocompatibility 
Alg-Cellulose sulfate-PMCG Independent adjustment of capsule parameters 
HEMA-MMA
 
Improved mass transfer, stability and durability 
Agarose-polystyrene sulfonate Blocks the activation of complement via enhancing the activity of C1 
inhibitors. 
Alg-Agarose Increased mechanical stability 
Barium-alg Increased mechanical and chemical stability 
PDADMAC
 
Increased mechanical stability 
Alg-chitosan Increased biocompatibality 
PVA
 
Improved intracapsular nutrient transport 
Photopolymerised PEG- 
diacrylate 
Increased biocompatibilty 
 
According to Code of Federal Regulation (CFR) in the Food and Drug 
Administration (FDA) of the United States of America [41, 42], calcium alginate is 
the calcium salt of alginate acid which is a natural polyuronide constituent of various 
species brown algae or seaweed [25, 26]. It had been approved as the one of the 
important biomaterials in regenerative medicine, nutrition supplements and also 
stabilizer. The chemical composition and sequence of alginate may vary widely 
because of the different species of algae. Principally, alginate are unbranched 
polysaccharides which are binary, linear copolymers consisting of (1→4) linked β-D- 
mannuronic acid (M) and α-L- guluronic acid (G) residues as shown in Figure 2.7 [6, 
25, 27]. 
 
Figure 2.7: Structural characteristics of alginate: (a) alginate monomers, (b) chain 
conformation, (c) block distribution [13] 
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By using various techniques for cell encapsulation the proposed polymeric materials 
can be explored. Each polymeric material that can be used must be biocompatible in 
order to obtain successful cell encapsulation. This may provide immune protection 
by isolating encapsulated cells from host tissue but also keeping the cells well 
distributed in capsules and maintaining the phenotype of cells. The rough surface of 
microcapsules must be avoided to prevent the immunological reactions when 
implanted. The feasibility of encapsulation of cells depends on the cell type and 
materials for encapsulation.  Table 2.4 shows the materials, the type of cells used for 
microencapsulation and their clinical applications. From the literature review, 
microencapsulation of epithelial cells is still rare and presented opportunity for 
research. 
A variety of parameters such as different concentration of coating alginate, 
variety in exposure time in second gelling solution, different gelling ions (both for 
core of alginate beads first and second gelling solution (for coating layer) and 
different washing solution (mannitol or saline), to see if this treatment can affect the 
binding and distribution of coating alginate in coated capsules [56]. 
In cell microencapsulation, alginate become the most common polymer employed 
because of its features. It is the selective binding of multivalent cations, which is the 
basis for hydrogels formation and the transition of alginate does not influenced by 
temperature. Alginates also possess a soft nature, making them physically similar to 
most native tissue. Transparent condition allow alginate hydrogels the routine 
analysis of cell entrapment using standard microscopical techniques and enable cell 
recovery without cell damage [54]. 
For this research study, the selection of alginate as microencapsulation 
polymer is promoting because of it properties which is can mimics the extracellular 
matrix (ECM) and supports cells functions and metabolism. 
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Table 2.4: Cell encapsulation approaches based on different alginate matrices [57] 
Material Cell Implantation site Application 
Alginate Bone marrow stromal cells, 
murine derived adiposed tissue 
stromal cells, islets of Langerhans 
Subcutaneous space, 
peritoneal cavity and 
under the kidney 
capsule 
Bone and cartilage 
engineering, 
diabetes and cancer 
Alginate 
(Atomization) 
Monocytes and mesenchymal 
stem cells 
In vitro study  
Alginate (with 
RGD) 
MC3T3-E1, myoblasts and 
satellite cells 
Muscle  Bone regeneration 
and muscle 
regeneration 
Alginate 
(Enzymatic 
modification) 
 In vitro study Increased stability 
Alginate 
(Chemoenzymatic 
modification) 
 In vitro study Increased stability 
Alginate 
(Photoreactive 
liposomes) 
Bone derived cells In vitro study Substrates 
containing cells 
immobilized in 
precise locations 
Alginate (Phenol 
moieyies)  
Crandall-Reese feline kidney 
cells 
In vitro study Increased stability 
 
Alginate-PLL-
alginate 
Embryonic stem cells, bone 
marrow mesenchymal stem cells, 
islets of Langerhans, chromaffin 
cells and myoblasts 
Peritoneal cavity, 
subarachnoid space 
and subcutaneous 
space 
Bone repair and 
regeneration, 
chronic neuropathic 
pain and anemia 
Alginate-PLL-
alginate  
(Covalent cross-
links between 
membranes)  
Islets of Langerhans and EL-4 
thymoma 
Peritoneal cavity Increased stability 
Alginate-PLL-
alginate 
(polymerization)  
 Peritoneal cavity  
Alginate-agarose Feline kidney cells and human In vitro study Subsieve-size 
capsules 
Alginate-chitosan Baby hamster kidney cells and 
human mesenchymal stem cells 
Subcutaneous space Tissue engineering 
Alginate-chitosan 
(Lactose modified 
chitosan)  
Chondrocytes  In vitro study Increased 
mechanical 
properties 
Alginate-PLO-
alginate 
Choroid plexus and islets of 
Langerhans 
Brain, peritoneal 
cavity and 
subcutaneous space 
Diabetes and 
neuroprotection 
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2.7 Different microencapsulation techniques 
2.7.1 Extrusion and dripping technique 
Extrusion method or technique is simple devices where the cell and biopolymer 
solutions-containing syringe being extruded through a nozzle or needle to be cross-
linked in a hardening solutions [27, 28]. When the way of controlled droplet 
formation is there, the method is known as prilling. In this type of system, external 
energy is required to reduce the droplet size [23, 27]. Hence, a few extrusion 
approaches to the production of microcapsules had been developed and introduced 
by previous researcher. This includes electrostatic generator, nozzle resonance 
technology, jet cutter, spinning disk and other common techniques [23, 27–30]. 
Figure 2.8 shows the extrusion technologies in producing microcapsules. Each of the 
technologies has different advantages and disadvantages when producing the 
microcapsules. 
 The disadvantage of simple dripping technique is that the microcapsules 
formed is very large to be used in biotechnological or medical applications. Dripping 
with concentric air jet can produced microcapsules small in size but only in small 
batches. This is different from dripping and spraying with electrostatic forces. There 
are potentials put in opposite sites between orifice and the gelation bath. With the 
slow flow rate, the technology can only produce small batch of microcapsules. 
Although rotating disk and jet cutter technologies can produce large batches of bead, 
but the size of the beads are too big [6].  
 Nonetheless, the vibration technology offers the best microcapsules 
production with uniform, monodisperse and small in size. The process can be 
controlled and easy to scale-up. For vibration technology, it can be applied to 
encapsulate living things, liquids and special features based on the end product 
requirement. 
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Figure 2.8: Extrusion technology [47] 
(a) (b) (c) (d) (e) 
(a) (b) 
(c) (d) 
(e) 
Simple dripping Dripping with a concentric air jet 
Dripping and spray with electrostatic 
forces 
Rotating disk and jet cutter 
technologies 
Vibration technology 
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2.7.2 Extrusion and vibration technology 
Different extrusion technologies for encapsulation of cells, microbes or any other 
liquids include by applying the vibration on a laminar jet for controlled break-up into 
monodisperse microcapsules.  A superimposed vibration in vibration technologies is 
conducted based on the principle that a liquid jet breaks up into equally sized 
microcapsules.  
 The encapsulation laboratory scale device  [6] had been produced to perform 
the experiment. In Figure 2.9, the main parts of the device were briefly described. 
The device is possibly used to encapsulate cells without any significant loss of cell 
viability. It also can produce capsules between 100 up to 2000 μm controlled by 
several parameters including the vibration frequency, nozzle size, flow rate and 
physical properties of the polymeric material used. 
 
Figure 2.9: Main part of encapsulation device with a concentric nozzle [6] 
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Several methods for producing protein-immobilised calcium alginate beads have 
been reported [61, 62]. In Figure 2.10, the study reported by [63], shows the used of 
loudspeaker as vibrating device. The sine wave sound generator is connected to the 
loudspeaker with the frequency set to 200 Hz. Using this method, the small size 
microcapsules below 20 µm that produced were easily arrange with the help of 
optical tweezers or laser manipulation. However, another flexible silica capillary 
connected to the syringe needle might increase the complexity of this system.  
 
 
Figure 2.10: Apparatus for producing alginate beads by the vibration method [63] 
2.7.3 Microfluidic  
Microfluidic has emerged as a powerful platform for the generation of micoparticles 
with tailored structure and properties. This technique allows direct integration of 
different input fluid into the PDMS microfluidic channel as shown in Figure 2.11. 
Flexible silica 
capillary 
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The system involves with cells suspended in culture media that is dispersed through 
the channel continuously flushed with oil. Although microscale techniques has been 
applied to biological for nearly two decades, but it has not been widely integrated as 
common tools in biological laboratories.  This could be due to the tedious 
preparation procedures. However, the complexity of the microfluidic design has 
increased tremendously with more functionalities and flow channels. 
 
 
Figure 2.11: Microfluidic channel [64] 
2.7.4 Electrospray 
Previously, Bugarski et al. first reported the preparation of microcapsule using 
electrospray technique. The technique had demonstrated the effective preparation of 
size-controlled microcapsules. However this technique comes with high complexity 
of operation [65] and come with a risk since it required the used of high voltage 
generator. Basically, electrospray system consists of syringe pump, stainless steel 
needle and high voltage generator.  
The microcapsules were generated by extruding the polymeric material or solution 
through the stainless steel needle using a syringe pump. The electric force or voltage 
generator was applied between the gelling bath and the needle [11, 20–22]. As shown 
in Figure 2.12, it is the example of the electrospray device setup. Although the device 
seem to be simple and easy to conduct, but the electric force supply might be the risk 
to the user. 
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